Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kriegsmann

Showing results (251-260 of 366) with videos related to

Pageof 37
Sort By:
International Journal of Oncology|February 25, 2022
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinomaMarc A Schneider, Sarah Richtmann, Anna R Gründing, et al.
JCO Clinical Cancer Informatics|October 29, 2025
Machine Learning Designed for Any Hematologic Flow Cytometry Data SetJohannes Mammen, Calin-Petru Manta, Sarah Richter, et al.
Frontiers in Oncology|May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung CancerMei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Cell Death & Disease|November 19, 2022
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilitiesYosuke Yamada, Djeda Belharazem-Vitacolonnna, Hanibal Bohnenberger, et al.
Oncotarget|June 21, 2016
Molecular driver alterations and their clinical relevance in cancer of unknown primary siteHarald Löffler, Nicole Pfarr, Mark Kriegsmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Tissue factor expression in an animal model of hydronephrosisT Wendt, Y M Zhang, A Bierhaus, et al.
Oncotarget|October 10, 2014
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differencesMark Kriegsmann, Volker Endris, Thomas Wolf, et al.
Cancer Research|July 12, 2022
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never SmokersTimo B Trefzer, Marc A Schneider, Katharina Jechow, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritisP K Petrow, D Wernicke, C Schulze Westhoff, et al.
Cancers|April 3, 2021
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal CancerMartina K Zowada, Stephan M Tirier, Sebastian M Dieter, et al.
Pageof 37

Showing results (251-260 of 366) with videos related to

Sort By:
Pageof 37
International Journal of Oncology|February 25, 2022
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinomaMarc A Schneider, Sarah Richtmann, Anna R Gründing, et al.
JCO Clinical Cancer Informatics|October 29, 2025
Machine Learning Designed for Any Hematologic Flow Cytometry Data SetJohannes Mammen, Calin-Petru Manta, Sarah Richter, et al.
Frontiers in Oncology|May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung CancerMei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Cell Death & Disease|November 19, 2022
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilitiesYosuke Yamada, Djeda Belharazem-Vitacolonnna, Hanibal Bohnenberger, et al.
Oncotarget|June 21, 2016
Molecular driver alterations and their clinical relevance in cancer of unknown primary siteHarald Löffler, Nicole Pfarr, Mark Kriegsmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Tissue factor expression in an animal model of hydronephrosisT Wendt, Y M Zhang, A Bierhaus, et al.
Oncotarget|October 10, 2014
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differencesMark Kriegsmann, Volker Endris, Thomas Wolf, et al.
Cancer Research|July 12, 2022
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never SmokersTimo B Trefzer, Marc A Schneider, Katharina Jechow, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritisP K Petrow, D Wernicke, C Schulze Westhoff, et al.
Cancers|April 3, 2021
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal CancerMartina K Zowada, Stephan M Tirier, Sebastian M Dieter, et al.
Pageof 37